CLASS I ONGOING Device recall · Reported 19 Aug 2026 · FDA Enforcement Report

Elevaris Sodium Chloride Injection recalled by Spectra Medical Devices

Spectra Medical Devices is recalling Elevaris Sodium Chloride Injection, 0.9%, USP, distributed in California, Florida, North Carolina, Oklahoma, Texas, Virginia. The recall was initiated on 6 Jul 2026 and the FDA has classified it as Class I.

Check your package

Lot, batch or date codesLot Code: Product codes: 1510-1 (individual ampule) / 1510-2 (carton) Lots: AB3005, AB3006, AB3007, AB3008, AB3009, AB3010, AB4001, AB4002, AB4003, AB4004, AB4005 AB4006, AB5001, AB5002, AB5003, AB5004, AB5005,AB5006, AB5007, AB5008 No individual UDI, as this product is used only within convenience kits.
Quantity recalledTBD

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2873-2026
FDA event ID
98777
Recalling firm
Spectra Medical Devices, Wilmington, MA
Classification
Class I
Status
Ongoing
Recall initiated
6 Jul 2026
FDA classified
11 Aug 2026
Reported
19 Aug 2026
Type
Voluntary: Firm initiated
Reason category
Foreign Material

Timeline

6 Jul 2026Recall initiated by company
11 Aug 2026Classified by FDA+36 days
19 Aug 2026Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Manufacturing firm, Huons, was cited for issues regarding product quality and sterility assurance. If the product sterility is compromised, patients may be exposed to microorganisms, endotoxins, or foreign matter. This may trigger inflammatory responses, infections, micro-clots, and organ failure.

Foreign material recalls cover pieces of metal, plastic, glass, wood or other objects that got into the product during processing and could cause injury if eaten.

Product as listed by the FDA

Brand Name: Elevaris/Spectra Medical Devices Product Name: Sodium Chloride Injection, 0.9%, USP 10mL Ampule Model/Catalog Number: AMPUL10MLK. Sodium Chloride Flush for IV tubing systems and indwelling intravascular access devices.

Where it was distributed

Distributed in the United States to medical device kit packers in six (6) states - CA, FL, NC, OK, TX, VA.

CaliforniaFloridaNorth CarolinaOklahomaTexasVirginia

Questions about this recall

Why was it recalled?

Manufacturing firm, Huons, was cited for issues regarding product quality and sterility assurance. If the product sterility is compromised, patients may be exposed to microorganisms, endotoxins, or foreign matter. This may trigger inflammatory responses, infections, micro-clots, and organ failure.

Which lots are affected?

Lot Code: Product codes: 1510-1 (individual ampule) / 1510-2 (carton) Lots: AB3005, AB3006, AB3007, AB3008, AB3009, AB3010, AB4001, AB4002, AB4003, AB4004, AB4005 AB4006, AB5001, AB5002, AB5003, AB5004, AB5005,AB5006, AB5007, AB5008 No individual UDI, as this product is used only within convenience kits.

Where was it sold?

Distributed in the United States to medical device kit packers in six (6) states - CA, FL, NC, OK, TX, VA.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class I mean?

Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Spectra Medical Devices

All 2
ReportedClassRecallCompanyReasonWhere
DrugCLASS IILidocaine HCl Injection USP, mL, Single-Dose Ampules recalledLidocaine HydrochlorideSpectra Medical DevicesSterilityNationwide

Other Heart & Vascular Devices recalls

All 6,199